An Open Label Extension Study of STX209 in Subjects With Fragile X Syndrome
Clinical trial NCT01013480 · TERMINATED
Trial details
- NCT number
- NCT01013480
- Sponsor
- Seaside Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2012-12-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.